Adenovirus (Ad) early region 3 (E3) proteins that affect class I MHC- and TNFalpha-dependent host responses will be studied in vivo. Ad infections can be serious and even fatal in otherwise normal hosts especially children as well as cause fatal hepatic necrosis in immunosuppressed patients. It is therefore important to understand Ad pathogenesis and the effect of the E3 genes on this process. For some of the experiments in this proposal, E3 DNA has been introduced as a transgene in mice and expression of E3 mRNAs and proteins have been partially characterized. For other experiments, the E3 genes will be delivered in various human adenoviral constructs (wt and mutant), some of which have been shown to be pathogenic in liver. Individual E3 genes will be inserted also into the mouse Ad (MAV-1 or FL) that unlike most human Ads does not appear to have immunoregulatory genes in its E3 region. These studies will be facilitated by our recent discovery that MAV-1 causes a strain specific hemorrhagic encephalomyelitis that occurs in C57BL/6 mice but not in BALB/c. With these models, it will be possible to study the effects of acute murine disease and persistence of: (1) Ad gp19K, an E3 protein that downregulates transport of some class I MHC proteins from the endoplasmic reticulum to the cell surface, and thus reduces the cytotoxic T lymphocyte response to infection; (2) Ad E3 14.7K or the complex of 10.4K/14.5K proteins that inhibit the cytolytic activity of TNFalpha. The 10.4K and 14.5K proteins also accelerate internalization of the epidermal growth factor receptor whose effect on Ad disease is unknown. These studies involve matings to insert the E3 transgene into mice of different MHC haplotypes, because Ad gp19K binds preferentially to H-2/g and not H-2/k class I MHC molecules. To understand some of the organ and cell specific effects that will emerge from these pathogenesis studies, in situ techniques will be developed to measure the sites of E3 transgene activity induced by MAV-1.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA069703-08
Application #
2654217
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Wong, May
Project Start
1989-01-01
Project End
2000-01-31
Budget Start
1998-02-01
Budget End
1999-01-31
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Charles, P C; Chen, X; Horwitz, M S et al. (1999) Differential chemokine induction by the mouse adenovirus type-1 in the central nervous system of susceptible and resistant strains of mice. J Neurovirol 5:55-64
Bergelson, J M; Krithivas, A; Celi, L et al. (1998) The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol 72:415-9
Charles, P C; Guida, J D; Brosnan, C F et al. (1998) Mouse adenovirus type-1 replication is restricted to vascular endothelium in the CNS of susceptible strains of mice. Virology 245:216-28
Bergelson, J M; Cunningham, J A; Droguett, G et al. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-3